Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N O'Higgins

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Journal of the Royal College of Surgeons of Edinburgh|October 9, 2002
Parathyroid localisation--current practiceB Dijkstra, C Healy, L M Kelly, et al.
Irish Medical Journal|November 6, 2001
The value of sentinel node mapping for staging melanomaB Dijkstra, A Hill, L Kelly, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2005
Ets2 transcription factor in normal and neoplastic human breast tissueY Buggy, T M Maguire, E McDermott, et al.
British Journal of Cancer|May 1, 1995
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancerM J Duffy, J Blaser, C Duggan, et al.
Gut|October 1, 1972
A simultaneous combined pancreatic testS Nundy, J H Baron, J S Beales, et al.
Journal of Clinical Pathology|June 29, 2006
Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practiceM F Dillon, C M Quinn, E W McDermott, et al.
British Journal of Cancer|April 7, 1998
Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancerA G Remacle, A Noël, C Duggan, et al.
British Journal of Cancer|January 1, 1997
Plasminogen activator inhibitor type 2 in breast cancerC Duggan, S Kennedy, M D Kramer, et al.
British Journal of Cancer|September 15, 2004
Overexpression of the Ets-1 transcription factor in human breast cancerY Buggy, T M Maguire, G McGreal, et al.
International Journal of Cancer|February 7, 2001
High levels of TIMP-2 correlate with adverse prognosis in breast cancerA Remacle, K McCarthy, A Noël, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Journal of the Royal College of Surgeons of Edinburgh|October 9, 2002
Parathyroid localisation--current practiceB Dijkstra, C Healy, L M Kelly, et al.
Irish Medical Journal|November 6, 2001
The value of sentinel node mapping for staging melanomaB Dijkstra, A Hill, L Kelly, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2005
Ets2 transcription factor in normal and neoplastic human breast tissueY Buggy, T M Maguire, E McDermott, et al.
British Journal of Cancer|May 1, 1995
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancerM J Duffy, J Blaser, C Duggan, et al.
Gut|October 1, 1972
A simultaneous combined pancreatic testS Nundy, J H Baron, J S Beales, et al.
Journal of Clinical Pathology|June 29, 2006
Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practiceM F Dillon, C M Quinn, E W McDermott, et al.
British Journal of Cancer|April 7, 1998
Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancerA G Remacle, A Noël, C Duggan, et al.
British Journal of Cancer|January 1, 1997
Plasminogen activator inhibitor type 2 in breast cancerC Duggan, S Kennedy, M D Kramer, et al.
British Journal of Cancer|September 15, 2004
Overexpression of the Ets-1 transcription factor in human breast cancerY Buggy, T M Maguire, G McGreal, et al.
International Journal of Cancer|February 7, 2001
High levels of TIMP-2 correlate with adverse prognosis in breast cancerA Remacle, K McCarthy, A Noël, et al.
Pageof 9